ChromaDex (CDXC) Misses Q2 EPS by 2c

ChromaDex (NASDAQ: CDXC) reported Q2 EPS of ($0.15), $0.02 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.8 million versus the consensus estimate of $7.44 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• KeyBanc Reiterates Overweight Rating on Brinker Int'l (EAT)
• LEEF Brands appoints Hirsh Jain to board as independent director